Often, we see a great deal of misinformation in the care of patients with diabetes, and often this misinformation is cen

[answerhappygod]

Often, we see a great deal of misinformation in the care of
patients with diabetes, and often this misinformation is centered
around the role and choice of medications. Many patients,
especially newly diagnosed patients, are prescribed medications
that do not fit into the scheme of the ADA /AACE guidelines / best
evidence-based practices - for instance, starting on Januvia
(sitagliptin) or Jardiance (empagliflozin) or Byetta (exenatide) as
initial monotherapy without a compelling indication or reason.
In this discussion, please talk about how patients get put on
these medications and why/how they should be transitioned to more
evidence-based treatments.
Now let’s consider the following case about thyroid
disorders. A 69-year-old man goes to his family doctor because
he has been feeling fatigued and lethargic. His doctor does a
complete evaluation. This patient had a myocardial infarction and
has a recurrent ventricular arrhythmia (treated with amiodarone).
The patient’s TSH is elevated and his T4 is
slightly decreased.
Please try and answer the above questions with a thorough
explanation and references